Oppenheimer & Co »

In8bio shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of In8bio (INAB) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $36k 24k 1.48

More positions owned by Oppenheimer & Co

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)

View all positions for Oppenheimer & Co

Top funds holding In8bio

Alyeska Investment Group
Franklin Resources
683 Capital Management
BIOS Capital Management
Stonepine Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Vanguard Group
Oppenheimer & Co
Texas Capital Bank Wealth Management Services
Captrust Financial Advisors
Northern Trust
XTX Topco
Northwestern Mutual Wealth Management Company
Tower Research Capital

View all funds holding In8bio